Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation

Prostate cancer is among the most common types of cancer in men. Early detection and proper medical intervention is crucial to ensuring successful treatment. Here we describe a patient clinically presenting with castrate-resistant prostate carcinoma. Comprehensive genomic profiling identified a PTEN...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Case Rep Oncol
Asıl Yazarlar: Kmak, Jamie A., Agarwal, Nikita, He, Yuting, Heilmann, Andreas M., Miller, Vincent A., Ross, Jeffrey S., Pal, Sumanta Kumar, Ali, Siraj M., Kilari, Deepak
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2020
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204854/
https://ncbi.nlm.nih.gov/pubmed/32399016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506625
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller